|
Press Releases |
|
 |
|
Monday, February 3, 2025 |
|
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies |
National Center for Geriatrics and Gerontology and Eisai Co., Ltd. announced today that Eisai has created the "Guidance on Reducing the Risk of Cognitive Decline and Nutrition" and the "Handbook for Developing Home Delivery Meals/Meal Kits that Contribute to Reducing the Risk of Cognitive Decline" under the supervision of NCGG. more info >> |
|
国立長寿医療研究センターとエーザイ、認知機能低下リスクの低減と栄養に関するガイダンス、および 宅配食/ミールキット開発の手引きを作成し、食品関連企業へ提供開始 |
国立研究開発法人国立長寿医療研究センター(理事長:荒井秀典、以下 国立長寿医療研究センター)とエーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫、以下 エーザイ)は、国立長寿医療研究センターの監修のもと、エーザイが「認知機能低下リスクの低減と栄養に関するガイダンス」(以下、「ガイダンス」)および「認知機能低下リスクの低減に寄与する宅配食/ミールキット開発の手引き」(以下、「手引き」)を作成し、宅配食/ミールキットサービスをはじめとする食品関連企業への提供を開始したことをお知らせします。 more info >> |
|
Tuesday, January 28, 2025 |
|
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease |
Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the Supplemental Biologics License Application (sBLA) for once every four weeks lecanemab-irmb (U.S. brand name: LEQEMBI) intravenous (IV) maintenance dosing. more info >> |
|
Wednesday, January 22, 2025 |
|
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company |
Eisai Co., Ltd. announced today that it has been listed in the 2025 Global 100 Most Sustainable Corporations in the World (Global 100), a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. more info >> |
|
エーザイ、「世界で最も持続可能な100社」に9回目の選定 |
エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫)は、このたび、カナダのメディア・投資調査会社コーポレートナイツ社が選定する「2025年 世界で最も持続可能な100社」(2025 Global 100 Most Sustainable Corporations in the World、以下「Global 100」)に選定されましたのでお知らせします。 more info >> |
|
Wednesday, January 15, 2025 |
|
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease |
Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Biologics License Application (BLA) for lecanemab-irmb (U.S. brand name: LEQEMBI) subcutaneous autoinjector (SC-AI) for weekly maintenance dosing. more info >> |
|
Tuesday, January 14, 2025 |
|
エーザイとバイオジェン・インク、早期アルツハイマー病治療剤「レケンビ(R)」の皮下注射製剤維持投与に関する 生物製剤承認申請を米国FDAが受理 |
エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫、以下 エーザイ)とバイオジェン・インク(Nasdaq:BIIB、本社:米国マサチューセッツ州ケンブリッジ、CEO:Christopher A. Viehbacher、以下 バイオジェン)は、このたび、ヒト化抗ヒト可溶性アミロイド β(Aβ)凝集体モノクローナル抗体「レケンビ(R)」(一般名:レカネマブ)について、皮下注射オートインジェクター(SC-AI)による維持投与(週一回投与)に関する生物製剤承認申請(BLA)が、米国食品医薬品局(FDA)に受理されたことをお知らせします。 more info >> |
|
Tuesday, January 7, 2025 |
|
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease |
A collaborative research group led by Professor Kenjiro Ono of the Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, and Eisai Co., Ltd. more info >> |
|
金沢大とエーザイ、レカネマブがアルツハイマー病の病態進行を抑制するメカニズムの一端を解明 |
more info >> |
|
Monday, December 23, 2024 |
|
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases |
Fujirebio Holdings, Inc., a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., Ltd. announced today that they have entered into a memorandum of understanding for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Hola Prime Launches Transformative CSR Initiatives to Support Education, Health, and Sustainability
Feb 8, 2025 08:00: JST
|
|
|
Hola Prime Launches Transformative CSR Initiatives to Support Education, Health, and Sustainability
Feb 8, 2025 07:00 HKT/SGT
|
|
|
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 7, 2025 22:59 HKT/SGT
|
|
|
uSMART Capital, LLC 正式獲批美國Finra券商牌照
Feb 7, 2025 22:59 HKT/SGT
|
|
|
KALEO Frontman JJ Julius Son and Entrepreneur Robert Wessman to Launch Unique Limited-Edition Wine Collection at WineParis
Feb 7, 2025 21:30 HKT/SGT
|
|
|
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 7, 2025 17:04 HKT/SGT
|
|
|
uSMART Capital, LLC 正式獲批美國FINRA券商牌照
Feb 7, 2025 16:58 HKT/SGT
|
|
|
uSMART Capital, LLC 正式获批美国FINRA 券商牌照
Feb 7, 2025 16:50 HKT/SGT
|
|
|
uSMART Capital, LLC 正式获批美国Finra券商牌照
Feb 7, 2025 16:22 HKT/SGT
|
|
|
TOYOTA、ハイエース(バン)に特別仕様車を設定
Feb 7, 2025 13:40: JST
|
|
|
トヨタ・モビリティ基金、交通事故死傷者ゼロを目指す「タテシナ会議」の分科会活動、取り組みの進展と今後の方向性を確認
Feb 7, 2025 13:40: JST
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
Feb 7, 2025 4:00 JST
|
|
|
Winvest Group Powers Web3.0 Expansion with Multi-Channel Financing
Feb 6, 2025 23:30: JST
|
|
|
U.S.-Based Blockchain Kadena and Croatian Football Federation (HNS) Partner to Revolutionize Fan Engagement
Feb 6, 2025 23:00 HKT/SGT
|
|
|
Winvest Group Powers Web3.0 Expansion with Multi-Channel Financing
Feb 6, 2025 22:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|